InvestorsHub Logo
Followers 33
Posts 2861
Boards Moderated 1
Alias Born 10/24/2015

Re: NY1972 post# 14

Monday, 07/25/2022 1:34:35 PM

Monday, July 25, 2022 1:34:35 PM

Post# of 32
The AEs from the LD chemo*. I expect more data (dose expansion is ongoing) from them at ASH. As for NVS, a pivotal trial is planned and DL2 (12.5M) is the recommended dose.

* Some very early clinical data testing an anti-GD2 CAR-T with constitutive signaling from an engineered IL-7 receptor
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LYEL News